BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
5871
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang T, Wang SC, Ye L, Maimaitiyiming Y, Naranmandura H. Targeting Viral Proteins for Restraining SARS-CoV-2: Focusing Lens on Viral Proteins Beyond Spike for Discovering New Drug Targets. Expert Opin Drug Discov 2023. [PMID: 36723288 DOI: 10.1080/17460441.2023.2175812] [Reference Citation Analysis]
2 Zareei S, Pourmand S, Amanlou M. Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.996005] [Reference Citation Analysis]
3 Odolczyk N, Klim J, Podsiadła-białoskórska M, Winiewska-szajewska M, Szolajska E, Zielenkiewicz U, Poznański J, Zielenkiewicz P. Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2. Front Mol Biosci 2022;9:983014. [DOI: 10.3389/fmolb.2022.983014] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345